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Abstract
Cholesterol transport is essential for many physiological processes, including steroidogenesis. In steroidogenic cells
hormone-induced cholesterol transport is controlled by a protein complex that includes steroidogenic acute regulatory
protein (StAR). Star is expressed as 3.5-, 2.8-, and 1.6-kb transcripts that differ only in their 39-untranslated regions. Because
these transcripts share the same promoter, mRNA stability may be involved in their differential regulation and expression.
Recently, the identification of natural antisense transcripts (NATs) has added another level of regulation to eukaryotic gene
expression. Here we identified a new NAT that is complementary to the spliced Star mRNA sequence. Using 59 and 39 RACE,
strand-specific RT-PCR, and ribonuclease protection assays, we demonstrated that Star NAT is expressed in MA-10 Leydig
cells and steroidogenic murine tissues. Furthermore, we established that human chorionic gonadotropin stimulates Star
NAT expression via cAMP. Our results show that sense-antisense Star RNAs may be coordinately regulated since they are co-
expressed in MA-10 cells. Overexpression of Star NAT had a differential effect on the expression of the different Star sense
transcripts following cAMP stimulation. Meanwhile, the levels of StAR protein and progesterone production were
downregulated in the presence of Star NAT. Our data identify antisense transcription as an additional mechanism involved
in the regulation of steroid biosynthesis.
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Introduction
Steroid hormones are essential for maintaining normal
homeostasis and reproductive capability. Biosynthesis of all steroid
hormones starts in the mitochondrion with conversion of
cholesterol into pregnenolone by the cholesterol side-chain
cleavage enzyme cytochrome P450 (P450scc; CYP11A1) [1].
Transport of cholesterol from the outer to inner mitochondrial
membrane, where the conversion to pregnenolone occurs,
constitutes the rate-limiting step of steroidogenesis [2,3]. This
trophic hormone-regulated step involves the formation of a
macromolecular signaling complex that includes the outer
mitochondrial membrane-localized translocator protein (TSPO,
18 kDa), TSPO-associated protein PAP7 (ACBD3), the regulatory
a subunit of cAMP-dependent protein kinase (PRKARIa),
steroidogenic acute regulatory protein (StAR; STARD1), the
voltage-dependent anion channel (VDAC), and extracellular
signal-regulated kinases (ERK 1/2 or MAPK3) and their upstream
activator (MEK1/2) [4,5].
In the adrenal and gonads, regulation of steroidogenesis is
mediated partially by mechanisms that enhance the transcription,
translation, and/or activity of StAR [6,7]. Studies have
demonstrated that regulation of StAR expression is complex,
involving interaction between a diversity of hormones/factors
and multiple signaling pathways [8,9]. Synthesized as a 37-kDa
precursor molecule, StAR is imported into mitochondria, where
it is cleaved to generate a 30-kDa mature form [10–13]. To
render this protein fully active in its capacity to support
cholesterol transfer, StAR phosphorylation by cAMP-protein
kinase A (PKA) [14] and ERK1/2 [5,15] is required. Moreover,
numerous transcription factors have been identified to bind the
Star promoter and mediate transcription of this gene [16].
Another important regulatory mechanism of Star transcription
involves acetylation and methylation of histones bound to the Star
promoter [17,18].
In addition, post-transcriptional mechanisms, such as polyad-
enylation, also regulate Star mRNA. Rodent steroidogenic cells
express two main transcripts (1.6- and 3.5-kb), as well as a minor
2.8-kb form [6,19,20], due to differential polyadenylation in exon
7. These transcripts share the same 59-untranslated region (59-
UTR) and open reading frame, differing only in their 39-UTR.
Thus a single protein is synthesized from all of them [20]. Mouse,
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that yield equivalent alternative transcripts [21–23]. The
synthesis and stability of the two predominant mRNAs are
differentially regulated. In different rodent steroidogenic cell
types, the 3.5-kb Star transcript is preferentially synthesized
relative to the 1.6-kb mRNA after cAMP stimulation and then
preferentially degraded after removal of the stimulus [24]. The
fact that these transcripts share the same promoter suggests that
mRNA stability is a critical regulatory mechanism of Star.M o s t
genes that are controlled at the level of mRNA stability are
involved in acute cellular responses to stimuli, such as early
response genes, cytokines, and inflammatory mediators [25–28].
Within its extended 39-UTR, the 3.5-kb Star form contains a
region containing AU-rich elements (AUREs) and a sequence
called the basal instability region (BIR) [19]. Studies have shown
that the zinc finger protein TIS11b binds to these AUREs to
enhance turnover of the 3.5-kb Star mRNA. A cAMP-stimulated
AURE-independent mechanism that targets selective turnover of
the 3.5-kb Star mRNA has also been suggested [29]. In addition,
the 39-UTR of the rodent Star gene also reveals putative
cytoplasmic polyadenylation elements (CPEs) flanking one of
the distal poly(A) signals [7]. Recruitment of CPE-binding
proteins (CPEBs) to cis-elements in the 39-UTR of mRNAs can
modulate their translation in response to different stimuli [30].
Alternatively, longer 39-UTRs frequently possess sites for
microRNA (miRNA)-targeted degradation [31]. Although the
impact of miRNAs on StAR expression has yet to be examined,
prospective miRNA sites have already been identified within the
39-UTR of rodent Star mRNA [19,32]. While evidence for
differences in StAR protein expression due to the distinct mRNAs
have not been reported, additional regulatory options resulting
from differential mRNA stability is most likely important in this
rapid response.
Recently, the discovery of natural antisense transcripts (NATs)
has added an additional level of regulation to gene expression.
NATs, also named endogenous antisense transcripts, are single-
stranded RNAs that are complementary to mRNA sequences (i.e.,
sense transcripts) [33]. These molecules can modulate the
expression of sense transcripts or influence sense mRNA
processing and stability [34]. Genome-wide transcriptional
analyses have revealed extensive antisense transcription [35–37].
Although the function of most NATs remains undetermined,
increasing experimental evidence indicates their involvement in
gene regulation [38,39], including genomic imprinting, alternative
splicing, X inactivation, mRNA stability, translational regulation,
RNA export, DNA methylation, and histone modification [40].
NATs are also involved in controlling developmental processes,
adaptation to various stresses, and responses to viral infection
[33,41,42]. These endogenous antisense transcripts may influence
gene expression by interacting directly with the sense transcripts
from which they are derived or affecting other targets that may be
involved in mRNA transcription, maturation, transport, and/or
translation [43,44].
As mentioned above, regulation of StAR protein is a complex
process. Given the functional diversity of NATs and growing
evidence of their regulatory impact on protein expression, we
investigated whether antisense transcription plays a role in
modulating StAR protein expression and thus steroidogenesis. We
identified a novel NAT that is perfectly complementary to Star
mRNA. We also demonstrated its expression in MA-10 Leydig cells
and steroidogenic murine tissues. Finally, we established that
human chorionic gonadotropin (hCG) increases Star NAT expres-
sion via cAMP in MA-10 Leydig cells. Taken together, these data
confirm the involvement of NATs in hormonal regulation.
Results
In silico prediction of NATs for the Star gene
To identify potential NATs specific to the Star mRNA, we
performed a computational analysis by aligning the murine Star
gene (Gene ID: 20845) with mouse expressed sequence tags (ESTs)
using BLAST and the UCSC Genome Browser [45]. Homologous
sequences were compared against the cDNA of the longest murine
Star mRNA (NCBI Reference Sequence: NM_011485) and
properties such as sequence orientation and localization of poly(A)
signals and tails were analyzed. According to these criteria, several
EST clones demonstrated transcription from the opposite
direction (Fig. S1) and are potential NATs for Star.
59 Rapid Amplification of cDNA Ends (59 RACE) screening
in MA-10 cells
Given that 10 to 20% of EST sequences in UniGene were
annotated in the wrong direction [46], reliable in silico screenings
must be based on stringent parameters which could underestimate
or exclude some genuine antisense transcripts. Nevertheless, we
proceeded to experimentally validate our bioinformatics results by
performing 59 RACE experiments on total RNA isolated from the
MA-10 Leydig tumor cell line. Three different groups consisting of
three sequence-specific primers were used for the RT, PCR, and
nested PCR analyses respectively (Fig. 1A and Table 1). Before
any reaction, RNA was treated with RNase-free deoxyribonucle-
ase I (DNase I) to eliminate any contaminating genomic DNA.
Moreover, the identity of the amplified products was confirmed by
sequencing in both directions. This analysis verified the presence
of antisense sequences of different sizes that were completely
complementary to Star mRNA (Fig. 1B). Many overlapped with
each other, suggesting that they could be fragments of a longer,
unique antisense sequence.
Star NAT expression in MA-10 cells
To evaluate the presence of a long Star antisense transcript,
sequence-specific RT-PCR was performed using DNase I-treated
total RNA from MA-10 cells. The relative orientation of
transcription was assessed by restricting which primer was present
during single-strand cDNA synthesis. For this purpose, the first
primer of the G3 group designed for the 59 RACE assay was used.
For the PCR and nested PCR amplifications, the remaining two
primers of the G3 group were used as reverse primers. The two
forward primers were designed based on the RACE results
(Fig. 2A).
Cloning and sequencing the PCR product confirmed the
presence of a 2757-bp transcript that was perfectly complementary
to the Star mRNA sequence, including parts of the coding region
(i.e., exons 4, 5, 6, and part of exon 7) and the 39-UTR of the
longest Star sense mRNA (Fig. 2B). Thus, hereafter we will refer to
this transcript as the Star NAT.
To verify this result, several negative controls were included. A
ribonuclease (RNase)-treated RNA control was analyzed to
identify any RNA contamination in the reaction. In addition,
RT-PCR of a DNase I-treated RNA sample without reverse
transcriptase was performed. Two controls were conducted in
order to evaluate the strand specificity of the reverse transcription:
first, an RT reaction conducted in the absence of primer and a
second RT reaction done in the presence of a non-specific primer.
PCR product was not detected from these negative control
reactions. Moreover, RT reactions were carried out at high
temperature (i.e., 50uC) in order to avoid primer-independent
cDNA synthesis [47] and to improve strand specificity in RT-
PCR.
Star Natural Antisense Transcript
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Since total RNA contains both polyadenylated [poly(A)
+] and
non-polyadenylated [poly(A)
-] RNA molecules. To determine the
class in which Star NAT should be categorized, MA-10 cell total
RNA was divided into two fractions and analyzed in parallel by
sequence-specific RT, PCR, and nested PCR following DNase I
treatment. Fig. 2C shows that Star NAT was amplified from
poly(A)
+ but not poly(A)
2 RNA, indicating that this transcript
belongs to the class of polyadenylated RNAs. However, neither a
classical polyadenylation consensus region nor a poly(A) tail was
detected in the Star NAT sequence.
To evaluate Star NAT missing 39end sequence, 39 RACE
experiments on DNase I treated- total RNA isolated from MA-10
cells were performed (Fig. 3A). Analysis of the amplified products
showed an extension on Star NAT sequence of 389-bp reaching
its poly(A) tail. We next performed a sequence-specific RT-PCR
to confirm that this new fragment is part of a full length Star NAT
transcript. Three primers were designed based on the results of
the 39 RACE experiments, one for the RT reaction and the
remaining two as reverse primers for PCR and nested PCR
amplifications (Table 1). Fig. 3B shows a PCR product that
confirmed the presence of a 3146-bp transcript that was perfectly
complementary to the Star mRNA sequence, including the 59-
UTR, the coding region and part of the 39-UTR of the longest
Star sense mRNA. Interestingly, the last 75-bp of Star NAT 39end
is complementary to the Star genomic sequence, beyond the 59
end of Star mRNA.
To further characterize this antisense transcript, the presence of
open reading frame (ORF) coding proteins was analyzed. Then,
probable amino acid sequences derived from this transcript were
compared against murine protein databases using BLAST. Star
NAT does not seem to encode any known protein unlike many
other antisense transcripts described in the literature [48]. We also
explored the possibility of a promoter region that regulates Star
NAT transcription; however, none was identified within the Star
gene or its flanking genomic sequences.
Expression of Star NAT in mouse tissues
To further validate our observations, we studied the expression
of Star endogenous antisense transcripts in mouse tissues. 59 RACE
experiments were performed with total DNase I-treated RNA
isolated from mouse testis, ovary, adrenal gland, prostate, liver,
kidney, and brain. Fig. 4A demonstrates that steroidogenic tissues,
namely the ovary, adrenal gland, and testis, display a similar
outcome to MA-10 cells, suggesting the presence of overlapping
antisense sequences that were completely complementary to Star
mRNA. Also, other partially complementary antisense sequences
for Star were found in the liver, ovary, and brain.
Figure 1. Star natural antisense transcript screening in MA-10 cells. Total RNA was extracted from MA-10 cells and treated with DNase I. 59
RACE was performed using three different sets of three sequence-specific primers for RT, PCR, and nested PCR. Following agarose gel electrophoresis,
bands were eluted, and cloned into the pGEMH-T Easy vector for sequencing. The results were analyzed by BLAST and Vector NTITM Suite 8 software.
A. Upper panel. Schematic diagram showing the relative location of the three groups of primers (G1, G2, and G3) used. Lower panels. Representative
images of the nested PCR products generated by amplification with each primer group (lane 2). Lane 1 shows the DNA molecular weight ladder.
Arrows indicate the apparent sizes (in base pairs, or bp) of the eluted bands. B. Schematic diagram showing the representative sequences of the
resultant products. Sizes are indicated in bp. Complementarity and relative location of these sequences with the Star transcript sequence is indicated.
doi:10.1371/journal.pone.0022822.g001
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tissues, sequence-specific RT, PCR, and nested PCR were
conducted as described previously for MA-10 cells. A single band
of the expected size was detected and the identity of this
amplification product was confirmed by sequencing. Fig. 4B
shows that the Star NAT found in the MA-10 cell line is also
expressed in classical steroidogenic tissues, such as adrenal gland,
ovary, testis, and brain.
Hormonal regulation of Star NAT expression
To elucidate a possible functional role for Star NAT expression,
hormonal regulation of this transcript was assessed. Semi-
quantitative RT-PCR was performed on MA-10 cells treated
with human chorionic gonadotropin (hCG) for varying times (i.e.,
0 to 6 h). Fig. 5A demonstrates that hCG-induced Star NAT
expression was time-dependent. Maximum levels were observed
after 2 to 3 h of hormone stimulation. Star NAT expression also
increased in a time-dependent manner when cells were stimulated
with cAMP (Fig. 5B), with maximum levels observed 3 h after
stimulation.
To support these data, an RNase protection assay (RPA) was
conducted to confirm the presence of the antisense transcript. In
this experiment, MA-10 cells were incubated with 8Br-cAMP
(1 mM) for varying times. Total RNA was extracted, treated with
DNase, and then co-precipitated with single chain riboprobes
specific to the Star mRNA sense strand and NAT (Fig. 6A).
Hybridization and RNase A digestion were subsequently per-
formed. Moreover, yeast tRNA with and without RNase treatment
were used as controls. Fig. 6B shows that, consistent with the RT-
PCR data, cAMP treatment increased Star NAT expression levels
in a time-dependent manner. This experiment also demonstrated
coordinated regulation of both sense and antisense Star transcripts
after hormone stimulation. Since the Star sense probe targeted the
coding region, joint expression of the three sense mRNAs (1.6-,
Table 1. Oligonucleotide sequences used in this study.
Reaction Primer Sequence (59 –3 9)
59 RACE G1 Group RT G1.1 TGAATCGCTCCAAGTTCCAGGCCAGCT
PCR G1.2 CCAGCTTGGACCCCAGTGAGACCGTCT
nested PCR G1.3 GCCTGGCTCAGAGCTAGCAGCTTCCTTA
G2 Group RT G2.1 CCAGCAGCTACGAACAGGGGATG
PCR G2.2 CGGGAACTGTTGTCTTACCAGCTCCAAA
nested PCR G2.3 ACCATCATCGTGCCGACTTCCCT
G3 Group RT G3.1 TCCAGCAGGGAGAGGTGGCTATGCAGA
PCR G3.2 GGCTGGAAGAAGGAAAGCCAGCAGGAGA
nested PCR G3.3 AAGATGGTGCCAGATGTGGGCAAGGTGT
39 RACE PCR G4.1 ACACCTTGCCCACATCTGGCACCATCTT
Nested PCR G4.2 CCTGCTGGCTTTCCTTCTTCCAGCCTT
Star NAT amplification RT G3.1 TCCAGCAGGGAGAGGTGGCTATGCAGA
PCR Fw.1 CCCTCGCTCACCTTAAAGCACCG
G3.2 GGCTGGAAGAAGGAAAGCCAGCAGGAGA
nested PCR Fw.2 GCAAATGATGGGGGTTACCCACA
G3.3 AAGATGGTGCCAGATGTGGGCAAGGTGT
Star NAT full amplification RT Rv.RT TTATCTCAAGTGATGATGCACAGCCTT
PCR Fw.1 CCCTCGCTCACCTTAAAGCACCG
Rv.1 CTTCCACGGGAAGCATTTAAGGCA
nested PCR Fw.2 GCAAATGATGGGGGTTACCCACA
Rv.2 CATTTAAGGCAGCGCACTTGATCT
Semiquantitative RT-PCR Star NAT RT G3.1 TCCAGCAGGGAGAGGTGGCTATGCAGA
PCR Fw.Nat CCTGGCTCCCAATTTATACC
Rv.Nat TAGGCTGAACACCCATTAACATT
L19 RT Random primers (Promega)
forward L19.Fw GAAATCGCCAATGCCAACTC
reverse L19.Rv TCTTAGACCTGCGAGCCTCA
Star Sense 1 forward Fw.S1 AAACAGAGGTCCTTATGGCTGC
RT/reverse Rv.S1 GGTGAGCAATAAATATCAGTGAAGG
Star Sense 2 forward Fw.S2 TTTAATCCCAACACTCAAGTGG
RT/reverse Rv.S2 CCTGGAACAGGAATGTTATAGC
Star Sense 3 forward Fw.S3 GGGACGAAGTGCTAAGTAAGATGG
RT/reverse Rv.S3 GGTCAATGTGGTGGACAGTCC
doi:10.1371/journal.pone.0022822.t001
Star Natural Antisense Transcript
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the antisense transcript exists simultaneously with its sense
counterpart.
For further confirmation, this experiment was repeated using a
Star NAT probe that was complementary to the antisense
transcript in a different region, its 39-end. Identical results were
obtained with this approach (Fig. 6C), thereby validating our
methodology as well as the presence and hormonal regulation of
Star NAT via cAMP. These findings suggest that Star NAT may
play a role in hormonal regulation of StAR protein expression and
therefore steroid synthesis.
Effect of Star NAT overexpression on Star sense
transcripts, StAR protein levels, and steroid production
To investigate the functional role of Star NAT expression in
steroid synthesis, MA-10 cells were transiently transfected with a
pcDNA3.1(+) vector expressing Star NAT. At 24 h post-transfec-
tion, cells were stimulated with 8Br-cAMP for varying times. Total
RNA, mitochondria, and culture media were harvested and
analyzed. First, the expression levels of Star sense transcripts were
determined by semi-quantitative RT-PCR. Since the three Star
mRNAs differ only within their 39-UTR, discriminating between
them was difficult. Thus, three primer pairs targeting different
regions of mouse Star mRNA were used (Fig. 7A and Table 1).
This analysis revealed that Star NAT overexpression had a
differential effect on Star sense transcripts expression (Fig. 7B
and C). While no significant variation was found in the level of the
3.5-kb transcript, a dramatic increase was observed when the 2.8-
and 3.5-kb forms were determined together, indicating that Star
NAT overexpression increases 8Br-cAMP-induced expression of
the 2.8-kb mRNA. When the levels of all three Star sense
transcripts were examined jointly, this increase was also detected.
Nevertheless, this experiment did not allow us to evaluate the
contribution, if any, of the 1.6-kb mRNA in the observed effect.
Thus, to address this and establish the selectivity of Star NAT,
the expression levels of Star sense transcripts in transfected MA-10
cells was determined by Northern blot analysis. Although relatively
less sensitive, this assay enabled us to evaluate each mRNA
individually. The data confirmed that Star NAT overexpression
increased 8Br-cAMP-promoted 2.8-kb and 1.6-kb Star mRNAs
expression after 4 and 6 h of stimulation respectively, while
expression of the 3.5-kb transcript was unaffected (Fig. 8A and B).
Figure 2. Star NAT expression in MA-10 cells. Total RNA was
extracted from MA-10 cells and treated with DNase or RNase prior to
sequence-specific reverse transcription, followed by PCR/nested PCR
and sequencing. A. Schematic diagram showing the RT primer (G3.1),
PCR primers (Fw.1 and G3.2), and nested PCR primers (Fw.2 and G3.3)
used in these experiments. A schematic representation of the full Star
NAT sequence obtained after sequencing the PCR products is shown.
B. Representative image of the RT-nested PCR product, the identity of
which was confirmed by sequencing. +R, RNase-treated RNA control;
-RT, no reverse transcriptase RT-PCR control; -p, RT reaction in the
absence of primer; pi, RT reaction in the presence of a non-specific
primer; MW, DNA molecular weight ladder. Arrows indicate apparent
sizes in bp. C. Poly (A)
+ RNA was purified from total MA-10 cells RNA
using oligo(dT) cellulose chromatography. After DNase I treatment,
specific RT, PCR and nested PCR were conducted as indicated above. A
representative image of the PCR product is shown.
doi:10.1371/journal.pone.0022822.g002
Figure 3. Star NAT 39 end characterization. A. Total RNA was
isolated from MA-10 cells and treated with DNase I. 39 RACE was
performed using two sequence-specific primers for PCR and nested PCR
amplifications. Following agarose gel electrophoresis, bands were
eluted, and cloned into the pGEMH-T Easy vector for sequencing. The
results were analyzed by BLAST and Vector NTITM Suite 8 software. Left
panel. Schematic diagram showing the relative location of the
sequence-specific primers used. Right panel. Representative image of
the nested PCR product generated. MW, DNA molecular weight ladder:
-RT, no reverse transcriptase RT-PCR control. Arrows indicate the
apparent sizes in bp. B. Total RNA extracted from MA-10 cells was
treated with DNase or RNase prior to sequence-specific reverse
transcription, followed by PCR/nested PCR and sequencing. Upper
panel. Schematic diagram showing the RT primer (Rv.RT), PCR primers
(Fw.1 and Rv.1), and nested PCR primers (Fw.2 and Rv.2) used in these
experiments. A schematic representation of the full Star NAT sequence
obtained after sequencing the PCR product is shown. Lower panel.
Representative image of the RT-nested PCR product. +R, RNase-treated
RNA control; -RT, no reverse transcriptase RT-PCR control; -p, RT
reaction in the absence of primer; pi, RT reaction in the presence of a
non-specific primer; MW, DNA molecular weight ladder. Arrows indicate
apparent sizes in bp.
doi:10.1371/journal.pone.0022822.g003
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mitochondria from transfected cells. Star NAT overexpression
caused a significant decrease in StAR protein after 4 to 6 h of
stimulation (Fig. 9A and B). This result was supported by a
concurrent reduction in progesterone production, as determined
by radioimmunoanalysis of the cell culture medium (Fig. 9C).
Compared to mock-transfected cells, progesterone levels in Star
NAT-transfected cells decreased 10 to 15% following incubation
with 8Br-cAMP for 3 to 4 h. A 30% decrease was observed after
6 h of cAMP stimulation. Altogether these results indicate that,
after 4 h of 8Br-cAMP stimulation, Star NAT elicits a differential
effect on the three Star sense transcripts, which ultimately results in
reduced StAR protein levels and steroid production. From these
results, we conclude that Star NAT hormone-regulated expression
may be involved in modulating StAR protein expression, a
complex process in which post-transcriptional regulation of
mRNAs is required.
Discussion
NATs have been implicated in numerous mechanisms that
affect, directly or indirectly, virtually all levels of transcriptional
control of eukaryotic gene expression [38,44].
Here we have identified a new endogenous antisense transcript
that we named Star NAT because it complements the Star mRNA
sequence, thus playing a role in the regulation and function of
StAR. We have demonstrated its expression in MA-10 Leydig cells
and steroidogenic murine tissues. Furthermore, we have estab-
lished that hCG increases Star NAT expression via cAMP. This
study constitutes one of a few experimentally proven examples of
hormonal regulation of antisense transcripts.
Star NAT is 3146-bp long and has full sequence complemen-
tarity to the spliced StAR sense 3.5-kb transcript. Similar
overlapping and length characteristics have been described for
other antisense transcripts [49]. Based on a 200-nucleotide cut-off
according to RNA purification protocols, antisense transcripts are
classified as short RNAs and long non-protein-coding RNAs [48].
The latter are often several hundred (to thousands) of nucleotides
in length and display strict homology to their corresponding sense
sequence [38,50]. While NATs may contain potential ORFs, most
are non-coding [35]. We found that Star NAT does not translate
Figure 4. Star NAT expression in mouse tissues. A. Total RNA was
extracted from different mouse tissues and treated with DNase I. 59
RACE was performed as described in Fig. 1. A representative image of
the RT-nested PCR products generated using the G1 and G3 primers is
shown. MW, DNA molecular weight ladder. B. Star NAT sequence-
specific reverse transcription was performed using DNase I-treated total
RNA from different mouse tissues, followed by PCR/nested PCR as
described in Fig. 2. L19 mRNA, a housekeeping ribosomal protein, was
used as a loading control. A representative image of the RT-nested PCR
product is shown. The identity of the amplification products was
confirmed by sequencing.
doi:10.1371/journal.pone.0022822.g004
Figure 5. Analysis of hormone-stimulated Star NAT expression
by RT-PCR. MA-10 cells were incubated with hCG (20 ng/ml) (A)o r
8Br-cAMP (1 mM) (B) for the indicated times. Total RNA was extracted
and treated with DNase I. Semi-quantitative sequence-specific RT-PCR
was performed to evaluate Star NAT expression. L19 mRNA expression
was evaluated as a loading control. The images of representative
agarose gels are shown. The sizes of the amplified products are
indicated in bp. For each time point, the optical density (OD) of Star
NAT expression was quantified and normalized to the corresponding
L19 mRNA level. Graphs show the relative expression levels of Star NAT.
Data are presented as an average 6 SD of four independent
experiments. * P,0.05 and ** P,0.01 vs. non-stimulated cells. -RT, no
reverse transcriptase RT-PCR control; -p, RT reaction in the absence of
primer; pi, RT reaction in the presence of a non-specific primer.
doi:10.1371/journal.pone.0022822.g005
Star Natural Antisense Transcript
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non-protein-coding RNA (ncRNA) [48].
Star NAT is polyadenylated since it was efficiently amplified
from poly(A)
+, but not poly(A)
2, RNA fractions. Moreover, its 39-
end was amplified in a 39 RACE experiment using an adapter
primer which initiates the first strand synthesis at the poly(A) tail of
mRNA. Sequencing confirmed the presence of a poly(A) tail in Star
NAT full sequence. Although many of the NATs found in mice
represent atypical transcripts, they tend to be localized in the
nucleus and non-polyadenylated [51]. Some NATs are mRNA-
like since they possess poly(A) tails and are expressed in the
cytoplasm [49,50] where they may potentially interact with
overlapping sense RNAs. It has been suggested that the poly(A)
tail is localized to the 39-end of antisense transcripts, similar to
sense transcripts [52]. The presence of a poly(A) tail would confer
increased stability to the molecule and thus indicates its
localization to the cytoplasm [53].
Three different mechanisms have been proposed to describe the
origin of antisense transcripts: 1) antisense synthesis could occur
either by transcription of the opposite strand of the corresponding
gene (cis-NATs) [54]; 2) transcription of a pseudogene (trans-
NATs) [55]; or 3) transcription of the sense mRNA by an RNA-
dependent RNA polymerase in the cytoplasm [52,56]. The
mechanism by which Star NAT is generated is an interesting
Figure 6. Analysis of hormone-regulated Star NAT expression by RNase protection assay (RPA). A. MA-10 cells were incubated with 8Br-
cAMP (1 mM) for the indicated times. Total RNA was extracted and then treated with DNase I. Single-chain Star sense and Star NAT RNA probes were
synthesized by in vitro transcription and labeled with [
32P] UTP. A schematic diagram illustrates the riboprobes used and their complementarity to
the corresponding transcript. B. RPA was performed using simultaneously two probes: the sense- Star RNA probe (Sense probe) that was
complementary to 566 bp of the coding region of sense transcripts, and the NAT- Star RNA probe (NAT probe 1) that was complementary to 719 bp
of Star NAT. A representative autoradiograph is shown. The negative control (tRNA (+) RNase) consisted of yeast tRNA instead of MA-10 RNA. The
tRNA (2) RNase control consisted of yeast tRNA without RNase treatment and was used to visualize the full-length probes. C. RPA was performed
using another Star NAT probe (NAT probe 2) that was synthesized to be complementary to 590 bp of Star NAT sequence in a region different from
the probe used in (B). A representative autoradiograph is shown. D. Graphs show the quantification (OD) of Star sense and NAT expression levels for
each time point expressed in arbitrary units. Data are presented as an average 6 SD of three independent experiments. * P,0.05 and ** P,0.01 vs.
non-stimulated cells.
doi:10.1371/journal.pone.0022822.g006
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transcription from the opposite strand of the Star gene. This is
consistent with the complementarity of Star NAT last 75 bp to Star
genomic sequence. However, the remaining sequence of Star NAT
is the complement of the spliced Star mRNA. The use of atypical
donor and acceptor sites for splicing of the antisense would be
required to obtain an exact match between sense and antisense
transcripts. Such sites have already been reported and bidirec-
tional transcription has also been proposed [52,57]. In this case,
the precise removal of six introns, as well as a promoter region that
regulates Star antisense transcription, would be required. However,
the current evidence does not support the existence of an origin
derived from bidirectional transcription at the gene locus, as has
been observed for other NATs [38,58,59].
Transcription of the Star NAT from a putative spliced
pseudogene sequence can be excluded because antisense RNA
arising from a pseudogene should exhibit several mutations and
therefore display partial complementarity with the sense mRNA
[55]. We found only a few point mutations at different positions
within the sequence of different clones, which we attributed to
classical PCR artifacts produced by the non-proofreading DNA
polymerase. Screening the mouse genome database also showed
no evidence of a Star pseudogene.
Nevertheless, Star NAT could be produced by transcription of
processed Star mRNA in the cytoplasm [60,61]. This possibility is
consistent with the precise and full complementarity of these
sense/antisense RNAs. Therefore, an enzyme homologous to
RNA-dependent RNA polymerase must be identified [62].
However, direct evidence for such an enzyme in mammalian
cells is still lacking [63].
The function of most NATs remains undetermined. Several
NATs may constitute transcriptional noise; however, there are
clear indications that some have a gene regulatory impact [38,64].
Furthermore, investigation of the entire antisense transcriptome
has identified common structural characteristics of some NATs
and point towards conserved themes in gene regulation by
antisense transcripts [39,42,51].
Expression of NATs in specific tissues provides clues about their
physiological role [64]. Analysis of the tissue distribution of Star
NAT revealed that it is expressed in steroidogenic tissues such as
testis, adrenal gland, ovary, and brain, suggesting a role in
regulating Star sense RNA expression. Comparative expression
Figure 7. Assessment of the effect of Star NAT overexpression on the level of Star sense transcripts by RT-PCR. MA-10 cells were
transiently transfected with a pcDNA3.1(+) vector expressing Star NAT (NAT) or an empty vector (mock) as a control. At 24 h post-transfection, the
cells were stimulated with 8Br-cAMP for the indicated times. Total RNA was extracted and semi-quantitative RT-PCR of Star sense transcripts was
performed. A. Schematic diagram showing the three primer pairs targeting different regions within the mouse Star mRNA used in these experiments.
Sense 1 primers target the 39-UTR of the longest 3.5-kb mRNA. Sense 2 primers target a region shared by the 2.8- and 3.5-kb Star mRNAs. Sense 3
primers target the coding region shared by all three sense transcripts. AAUAA, polyadenylation signals. B. Images of representative agarose gels are
shown. Arrows indicate the sizes in bp of the amplified products. L19 mRNA expression was evaluated as a loading control. C. For each band, the OD
of the level of Star sense transcripts was quantified and normalized to the corresponding L19 mRNA level. Graphs show the relative expression of Star
sense transcripts. Data are presented as an average 6 SD of three independent experiments. Data are presented as an average 6 SD of three
independent experiments. * P,0.05, ** P,0.01 and *** P,0.001 vs. mock-transfected cells stimulated during the corresponding time.
doi:10.1371/journal.pone.0022822.g007
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be correlated with the expression of the corresponding sense
transcript. However, these studies did not specify whether sense
and antisense transcripts are expressed within the same cell
[66,67], and frequently this linked expression is not found [68].
Moreover, a hormone-dependent increase in Star antisense RNA
expression was evidenced by RT-PCR and RPA. Our data show
that Star NAT expression reached a maximum level at 2 to 3 h
after stimulation and indicate that this effect was mediated by
cAMP. Our results are among the few recently described examples
of effective regulation of NAT expression by hormones [69-72].
Sense-antisense Star RNA co-expression in MA-10 cells was
demonstrated directly by RPA, suggesting that these transcripts
could be coordinately regulated. Mammalian RNAs that form
sense-antisense pairs have been reported to exhibit reciprocal
expression patterns [73]. However, other studies have concluded
that NATs display a tendency to be positively correlated with the
expression of their sense counterparts [35,74].
There are several mechanisms by which NATs can influence
the expression of their complementary transcripts. These mech-
anisms have been categorized into four main groups: those related
to transcription, RNA–DNA interactions, RNA–RNA interactions
in the nucleus, and RNA–RNA interactions in the cytoplasm [34].
Given the results presented here, Star NAT could form RNA
duplexes with its sense counterpart, which occurs frequently when
transcripts are long and completely overlapping [40,75]. However,
this duplex formation has only been detected in a few cases
[49,55,76] since such hybridization is a complex, transitory, and
fragile. Since Star NAT appears to be polyadenylated, formation of
a cytoplasmic RNA duplex could be postulated as part of its
mechanism in regulating StAR expression. Cytoplasmic sense–
antisense duplex formation can alter sense mRNA stability and/or
translation efficiency, mask protein-binding sites, or generate
endogenous small interfering RNA [34].
Star is expressed in steroidogenic cells as 3.5-, 2.8-, and 1.6-kb
transcripts that differ only in their 39-UTR, which is derived from
alternative polyadenylation sites in exon 7 through the 39-UTR
[20]. In the mouse MA-10 testis and Y-1 adrenal lines, 8Br-cAMP
stimulates the Star 3.5-kb mRNA preferentially. This level of
selectivity has also been observed with adrenocorticotropic
hormone stimulation in primary bovine adrenocortical cells. In
MA-10 cells, expression of the 3.5-kb mRNA peaks at 3 h but then
declines rapidly, whereas the 1.6-kb mRNA is maintained at a
steady-state level after 6 h of stimulation [24,29,77]. The 3.5-kb
Star mRNA is intrinsically much less stable when expressed from
vectors but is similarly translated [19]. This differential timing in
expression of the 3.5- and 1.6-kb Star transcripts is most likely due
to differences in post-transcriptional regulation. The time course of
Star NAT expression after hormone stimulation nearly paralleled
that of the Star 3.5-kb sense transcript. After achieving peak levels
2 to 3 h after stimulation, Star antisense RNA levels declined. In
addition, we did not observe any changes in the expression of
longer sense transcript levels after Star NAT overexpression,
suggesting that the antisense transcript may play a role in
stabilizing the 3.5-kb Star mRNA in the cytoplasm. The
overlapping region may affect mRNA stability by altering its
Figure 8. Assessment of the effect of Star NAT overexpression on the level of Star sense transcripts by Northern blot analysis. MA-10
cells were transiently transfected with a pcDNA3.1(+) vector expressing Star NAT (NAT) or an empty vector (mock) as a control. At 24 h post-
transfection, the cells were stimulated with 8Br-cAMP for the indicated times. Total RNA was extracted and northern blotting was conducted. A.A n
image of a representative northern blot is shown. A single-chain Star sense riboprobe was used in this assay. 18S rRNA was used as a loading control.
B. For each band, the OD of the expression level of each Star transcript was quantified and normalized to the corresponding 18S RNA level. Graphs
show the relative levels of Star sense transcripts. Data are presented as an average 6 SD of three independent experiments. * P,0.05 and ** P,0.01
vs. mock-transfected cells stimulated during the corresponding time.
doi:10.1371/journal.pone.0022822.g008
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regulatory proteins, such as AURE-binding proteins. Interestingly,
the 3.5-kb Star mRNA possesses an AURE within the extended 39-
UTR. The zinc finger protein ZFP36L1/TIS11b binds to
UAUUUAUU repeats in the extended 39-UTR, enhancing Star
mRNA turnover. Surprisingly, TIS11b expression is induced
concurrently with Star 3.5-kb mRNA. This co-regulation, despite
an adverse affect on mRNA stability, may be explained by the
presence of Star NAT [29]. Star antisense RNA could mask the
AURE motifs required for TIS11b-mediated destabilization.
Indeed, the antisense transcript overlaps the region that contains
the first two UAUUUAUU repeats shown to be necessary for
enhanced turnover. Therefore, cAMP could increase Star 3.5-kb
mRNA stability by concomitantly increasing Star NAT expression,
thus allowing for rapid StAR protein synthesis and cholesterol
transport. Later, Star antisense transcript levels could decline,
enabling destabilizing factors (e.g., AURE-dependent or -inde-
pendent) to promote mRNA decay. An increase in mRNA stability
provides a means to quickly respond to stimulation by cytokines,
growth factors, and protooncogenes [78,79].
Alternatively, longer 39-UTRs frequently possess target sites for
miRNAs, which mediate mRNA degradation [31]. Many NATs
may have the ability to mask miRNA-binding sites following
cytosolic RNA duplex formation [34]. Although the impact of
miRNAs on Star expression has yet to be examined, one
prospective miRNA (mmu-miR-706) site has already been
identified within the 39-UTR of rodent Star mRNA [19,32]. The
Star NAT sequence also overlaps this region, implying that a
miRNA-related mechanism may be involved.
Overexpression of Star NAT resulted in an increase in 2.8- and
1.6-kb Star mRNAs with a concomitant decrease in StAR protein.
Although much of the mechanism remains to be elucidated, we
can postulate that it does not involve an AURE-dependent
increase in stability because Star 2.8- and 1.6-kb transcripts lack
this sequence within their 39-UTR. Since low levels of StAR
protein were observed despite high levels of the mid-and short-
length mRNAs, these transcripts may not be actively translated,
but instead could be playing a role in regulating expression of the
3.5-kb mRNA.
Differences in how Star NAT and sense transcripts interact may
be due to variations in their secondary and tertiary structures, as
well as on the complexity of forming RNA duplexes [80]. The
exact mechanisms underlying the possible functional role of Star
NAT in the cAMP signal transduction pathway remain to be
investigated. Nevertheless, our data indicate that regulation of
StAR protein levels may depend on the presence of a natural
antisense transcript. Hormonal regulation of this transcript and its
role in balancing the expression of a crucial protein involved in
cholesterol transport emphasize the importance of these results.
Moreover, the involvement of NATs provides an additional
mechanism for rapid hormonal regulation of steroidogenesis.
Regulation of StAR expression is a complex process involving
transcriptional and post-transcriptional mechanisms. Our work
establishes the concept that StAR protein levels are modulated by
a fine balance between sense and antisense transcripts that enables
a quick response to hormonal stimulation. Participation of the Star
NAT in this process may explain the preferred formation of a
longer Star transcript, which facilitates the rapid synthesis of StAR
protein and cholesterol transport after hormone stimulation. In
conclusion, the present results demonstrate, for the first time, that
antisense transcription adds another level of control to gene
expression in steroid synthesis regulation.
Materials and Methods
Ethics statement
All animal experiments were performed according to the
guidelines recommended by the National Institute of Health and
protocols approved by the Institutional Ethical Committee from
the School of Medicine, University of Buenos Aires (approval ID
1072/05 and 1347/06 CD, School of Medicine).
Figure 9. Effect of Star NAT overexpression on StAR protein
levels and progesterone production. MA-10 cells were transiently
transfected with a pcDNA3.1(+) vector expressing Star NAT (NAT) or an
empty vector (mock) as a control. At 24 h post-transfection, the cells
were stimulated with 8Br-cAMP for the indicated times. Mitochondria
were isolated from transfected cells and western blotting was
performed. A. An image of a representative western blot is shown.
Membranes were sequentially blotted with anti-StAR and anti-OxPhos
complex III core 2 subunit (III Complex) antibodies. Two exposure times
are shown for StAR protein expression. B. For each band, the OD of the
expression level of StAR protein was quantified and normalized to the
corresponding III Complex protein. The relative levels of StAR protein
are shown. Data are presented as an average 6 SD of three
independent experiments. Insert. Scale amplification for the 0- and 1-
h time points. ** P,0.01 vs. mock-transfected cells stimulated during
the corresponding time. C. Progesterone concentration in the culture
medium was determined by RIA. Results are presented as an average 6
SD of four independent experiments. * P,0.05 and *** P,0.001 vs.
mock-transfected cells stimulated during the corresponding time.
doi:10.1371/journal.pone.0022822.g009
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The murine Star gene (Gene ID: 20845) was aligned with a
mouse EST database using BLAST [81]. The results were
visualized using the UCSC Genome Browser [45]. Homologous
sequences were compared against the murine cDNA derived from
the longest Star mRNA (NM_011485) and analyzed using the
Unigene database (NCBI), Blast2sequence (NCBI), and the Vector
NTITM Suite 8 (InforMax, Inc.) software. The latter program was
also used to identify open reading frames (ORFs) and the identity
of all sequenced fragments. A potential promoter region for Star
NAT transcription was evaluated using PROSCAN version 1.7
(bimas.dcrt.nih.gov/molbio/proscan).
Materials
8Br-cAMP, yeast tRNA, and ribonuclease A (RNase A) were
purchased from Sigma-Aldrich (St. Louis, MO). Waymouth
MB752/1 cell culture media, Opti-MEM and LipofectamineTM
2000 were obtained from Gibco-Life Technologies Inc. (Carlsbad,
CA). M-MLV reverse transcriptase (RT), T7 RNA polymerase,
GoTaqH DNA polymerase, pGEMH-T Easy vector, RNAsinH
inhibitor, RNase-free DNase RQ1, and other molecular biology
reagents were purchased from Promega (Madison, WI). RNase-
free Deoxyribonuclease I (DNase I) Amplification Grade, the
pcDNA3.1(+) vector, and oligonucleotides were obtained from
Invitrogen (Carlsbad, CA). Proteinase K was purchased from
Roche Diagnostics (Buenos Aires, Argentina). All other reagents
were of the highest grade available.
Mammalian cell culture and animals
The MA-10 cell line is a clonal strain of mouse Leydig tumor cells
that produces progesterone rather than testosterone as the main
steroid. MA-10 cells were generously provided by Mario Ascoli from
the UniversityofIowa,College ofMedicine (IowaCity,IA)andwere
handled as described previously [82]. The growth medium consisted
of Waymouth MB752/1 containing 1.1 g/l NaHCO3,2 0 m M
HEPES, 50 g/ml gentamicin, and 15% heat-inactivated horse
serum. Flasks and multiwell plates were maintained at 36uCi na
humidified atmosphere containing 5% CO2.
Human chorionic gonadotropin (purified hCG, batch CR-125
of biological potency 11900 IU/mg; gift from NIDDK, NIH) was
used to treat the MA-10 cells (20 ng/ml) for the times indicated.
8Br-cAMP (Sigma-Aldrich, St. Louis, MO) a permeable analog of
cAMP, was used to treat the MA-10 cells (1 mM) for the times
indicated.
According to approved protocols of animal care and use, tissues
were obtained from 60-day-old male and female Balb/c mice
(purchased from the School of Pharmacy and Biochemistry,
University of Buenos Aires, Buenos Aires, Argentina).
Total and poly(A)
+ RNA isolations
Total RNA from MA-10 cells and Balb/c tissues was isolated
with Tri-Reagent (Molecular Research Center, Inc. Cincinnati,
OH) according to the manufacturer’s instructions. Poly(A)
+ and
poly(A)
2 RNA from MA-10 cells were fractionated by oligo(dT)
cellulose chromatography as published [83]. RNA concentration
was quantitated in triplicate. Any residual genomic DNA was
removed by treating RNA with DNase I (15 min at room
temperature), which was subsequently inactivated by incubation
with 2.5 mM EDTA for 10 min at 65uC.
59 RACE
59 RACE was performed using the SMARTTM RACE cDNA
Amplification kit (Clontech Laboratories, Inc., Mountain View,
CA) according to the manufacturer’s instructions. Three different
groups of three sequence-specific primers were used for the RT,
PCR, and nested PCR analysis. A list of the oligonucleotides used
is shown in Table 1. Total DNase I-treated RNA was reverse-
transcribed using the first sequence-specific primer of each group.
PCR and nested PCR amplifications were conducted with the two
remaining oligonucleotides of each group. PCR conditions were:
one cycle at 94uC for 5 min; 5 cycles of 94uC for 30 s, 70uC for
30 s, 72uC for 3 min; 5 cycles of 94uC for 30 s, 68uC for 30 s,
72uC for 3 min; 25 cycles of 94uC for 30 s, 66uC for 30 s, 72uC for
3 min; and one cycle at 72uC for 10 min. PCR products were
resolved on 1.5% (wt/vol) agarose gels containing 0.5 mg/ml of
ethidium bromide to determine the molecular size of the
amplicons. Bands were visualized by UV transillumination and
images digitally recorded. Bands were excised, eluted, and ligated
into the pGEMH-T Easy vector, and then sequenced using T7/
SP6 primers and the ABI 3700 sequencer (Applied Biosystems-Life
Technologies, Carlsbad, CA). Results were analyzed using BLAST
and Vector NTITM Suite 8 software.
39 RACE
39 RACE was performed using the Invitrogen kit (Carlsbad,
CA) according to the manufacturer’s instructions. Total DNase I-
treated RNA was reverse-transcribed at 50uC using the adapter
primer (AP) which initiates the first strand synthesis at the poly(A)
tail of mRNA. PCR and nested PCR amplifications were
conducted with two sequence-specific primers and the two
universal amplification primers provided with the kit. A list of
the oligonucleotides used is shown in Table 1. PCR conditions
were: 1 cycle at 94uC for 5 min; 5 cycles at 94uC for 30 s, 64uC for
30 s, 72uC for 3 min; 5 cycles at 94uC for 30 s, 62uC for 30 s,
72uC for 3 min; 30 cycles at 94uC for 30 s, 60uC for 30 s, 72uC for
3 min; and 1 cycle at 72uC for 10 min. PCR products were
resolved on 1.5% (wt/vol) ethidium bromide-stained agarose gels
to determine the molecular size of the amplicons. Bands were
excised, eluted, and sequenced. Results were analyzed using
BLAST and Vector NTITM Suite 8 software.
RT-PCR and nested PCR amplifications
RNA was reverse-transcribed with M-MLV reverse transcrip-
tase and G3.1 or Rv.RT Star NAT-specific primers. RT reactions
were carried out at high temperature (50uC) to avoid primer-
independent cDNA synthesis [47] and to improve the strand
specificity of RT-PCR detection.
PCR amplification was performed using GoTaqH DNA
polymerase with the pair of primers listed in the corresponding
section of Table 1. Amplification conditions were the same as
those employed for 59 or 39 RACE assays. PCR products were
resolved on 1.0% (wt/vol) ethidium bromide-stained agarose gels,
excised, eluted, and finally cloned into a pGEMH-T Easy vector
for sequencing. As mentioned previously, RNA was treated with
RNase-free DNase I to eliminate genomic DNA contamination. In
addition, several negative controls were added. First, an RNase-
treated RNA control was included to determine whether any
nucleic acid contamination was present in the reaction. Second,
DNase-treated RNA was subjected to RT-PCR without reverse
transcriptase to ensure the lack of contaminants and effectiveness
of DNase I treatment. Finally, two controls were conducted in
order to asses the strand specificity of reverse transcription: RT
reactions were carried out in either the absence of primers, or in
the presence of a non-specific primer that is not related to the
target sequence. The latter targets the murine acyl-CoA synthetase
long-chain family member 4 mRNA. As expected, no PCR product
was detected from these negative control reactions.
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For semi-quantitative RT-PCR of Star NAT (amplicon size
460 bp), sequence-specific RT was performed using the G3.1
primer, followed by PCR amplification using the primers in
Table 1. L19 ribosomal protein mRNA (amplicon size 405 bp)
was used as internal standard to compare amplified amounts of
Star NAT from different RNA samples. In this case, the RT
reaction was conducted using random primers. PCR conditions
were one cycle at 94uC for 5 min, followed by 27 (for Star NAT) or
23 cycles (for L19)o f9 4 uC for 30 sec, 50uC for 30 sec, 72uC for
1 min, and one cycle at 72uC for 10 min. The number of cycles
used was optimized for each transcript to fall within the linear
range of PCR amplification.
For semi-quantitative RT-PCR of Star sense transcripts,
sequence-specific reactions were also performed. Since the three
StAR mRNAs differ only in their 39-UTR, it was difficult to
discriminate between them. Thus, three primer pairs targeting
different regions within mouse Star mRNA were used (Table 1).
One pair (Sense 1, amplicon size 435 bp, 22 cycles) was designed
to target only the extended 39-UTR of the longest 3.5-kb mRNA.
A second pair (Sense 2, amplicon size 719 bp, 23 cycles) targeted a
region that is shared by both 2.8- and 3.5-kb Star mRNAs. A third
pair (Sense 3, amplicon size 566 bp, 21 cycles) was specific to the
coding region and was thus common to all three Star sense
transcripts (1.6-, 2.8- and 3.5-kb). PCR conditions were the same
as described above. PCR products were resolved on 1.5% (wt/vol)
ethidium bromide-stained agarose gels to determine the molecular
size of the amplicons. Bands were visualized and transcript levels
quantitated using the computer-assisted image analyzer Gel-Pro
(IPS, North Reading, MA). Bands were excised, eluted, and cloned
into the pGEMH-T Easy vector for sequencing.
In vitro transcription of RNA probes
Single-chain Star sense and Star NAT [
32P]-labeled riboprobes
were synthesized by in vitro transcription. The Star NAT RNA
probe (NAT probe 1, 779 bp) was complementary to 719 bp of
Star NAT sequence. The template for its synthesis was a pGEMH-
T Easy vector containing a Star sense fragment amplified by semi-
quantitative RT-PCR using the Sense 2 primer pair and cloned in
the sense position relative to the T7 RNA polymerase promoter. The
Star sense RNA probe (sense probe, 626 bp) was complementary to
566 bp of the coding region of sense transcripts. The template for
its synthesis was a pGEMH-T Easy vector containing a Star sense
fragment amplified by semi-quantitative RT-PCR using the Sense
3 primer pair and cloned in the antisense position relative to the
T7 RNA polymerase promoter. Both plasmids were linearized with
Sal I and gel-purified. Another Star NAT probe (NAT probe 2,
680 bp) was synthesized to be complementary to 590 bp of the Star
NAT sequence in a region different from the previous NAT probe
used. The template for its synthesis was the Star cDNA sequence
cloned into a pGEMH-T Easy vector in the sense position relative
to the T7 RNA polymerase promoter as previously generated in our
laboratory [84]. This plasmid was linearized with Xho I and gel-
purified. The choice of probes size (779-, 626- and 680-bp) was
conducted according to the recommendations for RPA method-
ology [85]. Riboprobe synthesis reactions contained 0.5 -1 mgo f
linearized DNA plasmid; ATP, GTP, CTP (0.5 mM each); 12 mM
UTP; 100 mCi [a
32P] UTP (3000 Ci/mmol specific activity from
New England Nuclear, Boston, MA); 5 mM dithiothreitol; 20 U
RNAsinH inhibitor; 20 U T7 RNA polymerase; and 1X
transcription buffer. After 2 h at 37uC, DNA templates were
digested with RNase-free DNase RQ1. Transcription products
were resolved on 5% denaturing polyacrylamide gels (8 M urea).
Gel slices containing full-length transcripts were excised and
incubated overnight at 37uC in gel elution buffer (0.5 M
ammonium acetate, 1 mM EDTA, 0.1% SDS). The concentration
of RNA probes was 3–6610
4 cpm/ml, with a theoretical specific
activity of 3610
8 cpm/mg.
RNase Protection Assay (RPA)
Probes (sense and NAT 1 probes or NAT 2 probe alone,
72610
4 cpm each) and DNase I-treated total MA-10 cells RNA
(80 mg) were co-precipitated and hybridized overnight at 42uCi n
hybridization buffer (40 mM PIPES pH 6.4; 0.5 M NaCl, 1 mM
EDTA, 75% formamide). Then, RNase A (40 mg/ml) digestion
was performed for 1 h at 32uC. The reaction was stopped by
adding 0.5% SDS, followed by digestion with 12.5 mg/ml
proteinase K at 37uC for 15 min. Next, a phenol/chloroform
extraction was performed by adding 10 mg yeast tRNA to each
sample as carrier. After ethanol precipitation, protected double-
chain RNA fragments were subjected to a 5% denaturing
polyacrylamide gel (8 M urea) chromatography and then
visualized by autoradiography. The negative control (tRNA(+)R-
Nase) consisted of yeast tRNA instead of MA-10 RNA. No bands
are expected in this sample following digestion. The tRNA(2)R-
Nase control consisted of yeast tRNA without ribonuclease
treatment and was used to visualize the full-length probes.
Plasmid preparation and Star NAT overexpression by
transient transfection
Star NAT sequence (2757-bp length, obtained from RT-PCR
amplification based on 59RACE data), was subcloned from a
pGEMH-T Easy vector into the eukaryotic expression vector
pcDNA3.1(+) using Not I restriction sites.
For transient transfection, MA-10 cells were seeded the day
before and grown up to 80% confluence. Transfection was
performed with a pcDNA3.1(+) plasmid expressing Star NAT or an
empty vector in Opti-MEM medium and LipofectamineTM 2000
reagent according to the manufacturer’s instructions. Transfection
efficiency was estimated at approximately 30% by counting
fluorescent cells transfected with the pRc/CMVi plasmid
expressing enhanced green fluorescent protein (EGFP) [84].
Northern blotting
Samples of total RNA (24 mg) were resolved on 1.2% agarose/
2.2 M formaldehyde gels and transferred onto Hybond-N+ nylon
membranes (Amersham Biosciences, Stockholm, Sweden). A
single-strand Star sense RNA probe was synthesized by in vitro
transcription as we detailed previously here. After prehybridiza-
tion for 6 h at 56uC, blots were hybridized at 56uC overnight with
[
32P]-labeled riboprobe. The hybridization solution contained 6X
SSPE, 5X Denhardt’s solution, 0.5% formamide, 10 ng/ml yeast
tRNA, and 100 mg/ml denatured salmon sperm DNA. Blots were
subsequently washed twice with 2X SSPE (150 mM NaCl, 10 mM
NaH2PO4, 1 mM EDTA)/0.5% SDS at room temperature; twice
with 1X SSPE/0.1% SDS at 65uC; and twice with 0.1X SSPE/
0.1% SDS at 65uC. StAR hybridization signals were detected
using a Storm PhosphorImager (Amersham Biosciences, Stock-
holm, Sweden) and normalized to 18S RNA levels.
Protein quantification and western blotting
Mitochondria were isolated as described previously [86].
Mitochondrial proteins were determined by the Bradford assay
[87] using BSA as a standard. Proteins were separated by SDS-
PAGE (12% acrylamide gels) and transferred to PVDF mem-
branes (Bio-Rad Laboratories Inc., Hercules, CA) as described
previously [84]. Anti-StAR antibody was generously provided by
Star Natural Antisense Transcript
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Center, Lubbock, TX). Membranes were sequentially blotted with
anti-StAR and anti-OxPhos complex III core 2 subunit (Invitro-
gen, Carlsbad, CA) antibody, and immunoreactive bands were
detected using enhanced chemiluminescence (GE Healthcare,
Buckinghamshire, UK).
Radioimmunoanalysis (RIA) and statistics
Progesterone production in cell culture media was measured by
RIA as described previously [88]. Data are represented in ng/ml.
Statistical significance was determined using the Student’s t test or
analysis of variance (ANOVA) followed by the Student-Newman-
Kuels test.
Supporting Information
Figure S1 Genomic view of Star gene related RNA and
EST sequences. The potential antisense transcripts (NATs
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